Red blood cell transfusions enhance quality of life for MDS patients but require careful management due to potential risks ...

Luspatercept emerges as a preferred treatment for low-risk MDS, enhancing hemoglobin levels and quality of life, even in ...

This page lists all known medications that could potentially lead to 'Abnormal Erythropoiesis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Although erythropoietin (Epo) is commonly used as a therapy for anemia, recent studies have suggested that Epo therapy is associated with adverse outcomes. A new study shows that polymeric IgA1 ...

Background: Erythropoiesis-stimulating agents are used to treat anemia in patients with cancer. However, their safety and effectiveness is controversial. We did a systematic review of the clinical ...

Anemia in patients with cancer can be caused by a number of factors including blood loss, hemolysis, nutritional deficiencies, renal insufficiency, marrow infiltration, anemia of chronic disease and ...

THE anemia of renal insufficiency is associated with both increased red-cell destruction and impaired erythropoietic response to anemia. Variations in the relative importance of these 2 mechanisms and ...

For those affected by anemia, receiving the proper treatment can improve quality of life. The most common treatment is erythropoiesis-stimulating agents (ESAs), which can provide significant ...